Asker, 1 November 2023, 07:00 CET
Cambi announced its third-quarter results today, delivering the sixth consecutive quarter with EBITDA growth to a quarterly record of NOK 70 million. The company has now also reached its order intake estimate of NOK 1.2 billion for the period 2023-2024 within three of the eight quarters.
“I am incredibly proud of the team’s achievements this quarter, with both the Technology and Solutions segments continuing to deliver exceptional performance. With a solid year-to-date cash conversion ratio of 80% and a book-to-bill ratio of 2.1, we reiterate our guiding of paying a dividend of 60-80% of net profits in the coming two years.”
The results will be presented online today at 10:00 AM CET via livestream accessible at https://www.cambi.com/investors/livestream/.
Questions can be emailed to Investor Relations at firstname.lastname@example.org before and during the event and will be answered live after the presentation. A presentation recording will be accessible on the website.
The complete report and slides can be found on Cambi’s website (https://www.cambi.com/investors/reports-and-presentations/) and NewsWeb (https://newsweb.oslobors.no/).
For more information, please contact:
Cambi is a global biogas technology and solutions supplier for wastewater treatment plants and anaerobic digestion facilities. Since 1992, Cambi has retained market leadership through continuous innovation and a robust portfolio of proven and patented technologies. With strong project delivery and customer support capabilities, the company has delivered well-performing installations in 27 countries across the globe.
Cambi’s thermal hydrolysis process increases renewable energy output, reduces operational costs, and minimises greenhouse gas emissions. It is suitable for all biosolids outlets, including land application and thermal processes such as drying, pyrolysis, and incineration. Thermal hydrolysis is compatible with all sludge and waste treatment regulations and easy to integrate at new and existing anaerobic digestion sites.
Cambi is listed on Euronext Growth Oslo, a multilateral trading facility in Euronext, Europe’s largest stock exchange platform. Find out more at cambi.com.